Fundraising FoxNightWare
Hopkins, US · Delaware corporation · 1 known investors
Find your way into NightWare
Sign up to see every warm intro you have to NightWare
- Paths you didn't know you had: your email and LinkedIn already hold routes to the NightWare team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
NightWare is an FDA-cleared prescription digital therapeutic system designed to interrupt nightmares as they occur, improving sleep quality for patients with Nightmare Disorder, including those with PTSD. It is intended for physicians and patients seeking treatment for frequent, traumatic nightmares.
Founders & leadership
MT
Matthew TuckerChief Executive OfficerMatthew Tucker has 20+ years of experience in medical technology, including launching 30+ brands across devices, pharma, diagnostics, and digital therapeutics, and scaling teams from startup through global enterprise. He is CEO of NightWare, an FDA-cleared digital therapeutic for nightmares related to PTSD.
GH
Grady HannahNamed on SEC filing
MN
Board
MO
Michael OttBoard director
GM
Gerald MattysBoard director
Investors · 1
Exit 156 Capitallisted by Exit 156 CapitalCollegeville
How we know: Exit 156 Capital's portfolio page · funding news · sleepreviewmag.com · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$2.5M disclosed across 5 rounds · 2019–2026
▶$250KraisedMar 2026 · 1 investors · Other Health CareRule 506(b)
▶$250KraisedMar 2026 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Grady HannahDirector
- Matthew TuckerExecutive Officer, Director
- Gerald MattysDirector
- Richard NigonDirector
- Michael OttDirector
- Offering amount
- $2M
- Amount sold
- $250K
- First sale
- Feb 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.1MraisedSep 2025 · 18 investors · Other Health CareRule 506(b)
▶$1.1MraisedSep 2025 · 18 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew TuckerExecutive Officer, Director
- Michael OttDirector
- Gerald MattysDirector
- Grady HannahDirector
- Offering amount
- $3M
- Amount sold
- $1.1M
- Sales commissions
- $139K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Aug 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$700KraisedJul 2022 · 6 investors · Other Health CareRule 506(b)
▶$700KraisedJul 2022 · 6 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Grady HannahExecutive Officer, Director
- Gerald MattysDirector
- Nathan MichaelExecutive Officer, Director
- Matthew TuckerExecutive Officer, Director
- Offering amount
- $4.5M
- Amount sold
- $700K
- Sales commissions
- $438K
- Placement agents
- Cedar Point Capital, LLC
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$100KraisedFeb 2021 · 1 investors · Other Health CareRule 506(b)
▶$100KraisedFeb 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Grady HannahExecutive Officer, Director
- Nathan MichaelExecutive Officer, Director
- Matthew TuckerExecutive Officer, Director
- Tom VanderheydenDirector
- Offering amount
- $1.5M
- Amount sold
- $100K
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
▶$305KraisedMay 2019 · 8 investors · OtherRule 506(b)
▶$305KraisedMay 2019 · 8 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Michael NathanExecutive Officer, Director
- Grady HannahExecutive Officer, Director, Promoter
- Offering amount
- $2.8M
- Amount sold
- $305K
- First sale
- Apr 2019
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
SteamSteam is a digital platform for purchasing, downloading, and playing video games, serving both individual gamers and game developers worldwide.
JustWatchJustWatch is a streaming guide platform that aggregates availability information for movies, TV shows, and sports across multiple streaming services. The service helps viewers find where content is available to watch and provides personalized recommendations based on their preferred platforms.
Companies working in the same space as NightWare.
Non-dilutive funding · 4 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| U.S. Air ForceAir Force | Phase II | 2022 | $1.2M |
| U.S. Air ForceAir Force | Phase IISTTR | 2022 | $749.7K |
| U.S. Air ForceAir Force | Phase ISTTR | 2022 | $50K |
| U.S. Air ForceAir Force | Phase I | 2021 | $49.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does NightWare do?
- NightWare is an FDA-cleared prescription digital therapeutic system designed to interrupt nightmares as they occur, improving sleep quality for patients with Nightmare Disorder, including those with PTSD. It is intended for physicians and patients seeking treatment for frequent, traumatic nightmares.
- Who are NightWare's investors?
- NightWare's investors include Exit 156 Capital.
- How much funding has NightWare raised?
- NightWare has disclosed $2.5M raised across 5 rounds.
- Where is NightWare headquartered?
- NightWare is headquartered in Hopkins, US.